Urwashanza/europrocure-10-public-procurement huggingface dataset:
Public procurement notice: Voluntary Ex Ante Transparency Notice
Published: 2019-07-19
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (‘NSS’)
Country: UK
Contract type: Supplies
Procedure: Negotiated without a prior call for competition
CPV classification: 33600000: Pharmaceutical products
Estimated value: 3120000 GBP

Technical requirements: All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
The medicine awarded to this framework is, and will remain to be, protected by patent for the duration of the Framework Agreement.
The total value in Section II.1.7 and V.2.4 refers to the twenty one (21) months initial duration of the Framework Agreement and the options to extend for up to a total period of twenty seven (27) months.
For detail on the goods awarded to this framework, please contact the named person at the head of this notice.
The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority despatches the VEAT notice and the date on which the Authority proposes to conclude the relevant Framework Agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the Framework Agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the Framework Agreement has been entered into include the setting aside of the decision to award the Framework Agreement to the winning tenderer. The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.


Winner: Aventis Pharma Ltd Trading As Sanofi
Award value: 3120000
Public procurement notice: Voluntary Ex Ante Transparency Notice
Published: 2019-07-19
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (‘NSS’)
Country: UK
Contract type: Supplies
Procedure: Negotiated without a prior call for competition
CPV classification: 33600000: Pharmaceutical products
Estimated value: 100000 GBP

Technical requirements: All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
The medicine awarded to this framework is, and will remain to be, protected by patent for the duration of the Framework Agreement.
The total value in Section II.1.7 and V.2.4 refers to the twenty one (21) months initial duration of the Framework Agreement and the options to extend for up to a total period of twenty seven (27) months.
For detail on the goods awarded to this framework, please contact the named person at the head of this notice.
The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority despatches the VEAT notice and the date on which the Authority proposes to conclude the relevant Framework Agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the Framework Agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the Framework Agreement has been entered into include the setting aside of the decision to award the Framework Agreement to the winning tenderer. The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.


Winner: Shire Pharmaceuticals Ltd
Award value: 100000
Public procurement notice: Voluntary Ex Ante Transparency Notice
Published: 2019-07-19
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (‘NSS’)
Country: UK
Contract type: Supplies
Procedure: Negotiated without a prior call for competition
CPV classification: 33600000: Pharmaceutical products
Estimated value: 8741000 GBP

Technical requirements: All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
The medicine awarded to this framework is, and will remain to be, protected by patent for the duration of the Framework Agreement.
The total value in Section II.1.7 and V.2.4 refers to the twenty one (21) months initial duration of the Framework Agreement and the options to extend for up to a total period of twenty seven (27) months.
For detail on the Goods awarded to this framework, please contact the named person at the head of this notice.
The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority despatches the VEAT notice and the date on which the Authority proposes to conclude the relevant Framework Agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the Framework Agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the Framework Agreement has been entered into include the setting aside of the decision to award the Framework Agreement to the winning tenderer. The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.


Winner: Aventis Pharma Ltd Trading As Sanofi
Award value: 8741000
Public procurement notice: Voluntary Ex Ante Transparency Notice
Published: 2019-07-19
Buyer: WWCOiT im. M. Kopernika w Łodzi
Country: PL
Contract type: Supplies
Procedure: Negotiated without a prior call for competition
CPV classification: 33600000: Pharmaceutical products
Estimated value: 35280000 PLN
Award criteria: Lowest price

Technical requirements: Zgodnie z art. 67 ust. 1 pkt 1 lit. a Ustawy z dnia 29.1.2004 r. Prawo zamówień publicznych (tekst jednolity Dz.U. z 2018 r. poz. 1986 ze zm.). Zamawiający może udzielić zamówienia z wolnej ręki, jeżeli zachodzi co najmniej jedna z następujących okoliczności: dostawy, usługi lub roboty budowlane mogą być świadczone tylko przez jednego wykonawcę z przyczyn technicznych o obiektywnym charakterze – jeżeli nie istnieje rozsądne rozwiązanie alternatywne lub rozwiązanie zastępcze, a brak konkurencji nie jest wynikiem celowego zawężenia parametrów zamówienia.
Przedmiotem zamówienia są dostawy produktu farmaceutycznego Nusinersenum. Przedmiotowy produkt znalazł się w programie lekowym: leczenie rdzeniowego zaniku mięśni (B.102) na podstawie Obwieszczenia Ministra Zdrowia z dnia 27.12.2018 r. w sprawie wykazu refundowanych leków, środków spożywczych specjalnego przeznaczenia żywieniowego oraz wyrobów medycznych. Dz. Urz. Min. Zdr. 2018.123. Jedynym i wyłącznym producentem leku Spinraza (nusinersen) jest firma Biogen. Zgodnie z informacją przekazaną przez Biogen Poland Sp. z o.o. aktualnie jedynym dystrybutorem tego preparatu na terenie Rzeczypospolitej Polskiej w ramach programu lekowego - leczenia rdzeniowego zaniku mięśni jest hurtownia farmaceutyczna Farmacol S.A. z siedzibą w Katowicach, ul. Szopieniecka 77, POLSKA (Umowa podpisana zawarta została ze spółką córką hurtowni farmaceutycznej Farmacol S.A., spółką Farmacol Logistyka Sp. z o.o. z siedzibą w Katowicach, ul. Szopienicka 77, POLSKA). Dodatkowo preparat Spinraza (nusinersen) nie posiada żadnych odpowiedników o tej samej nazwie międzynarodowej (leku równoważnego) na terenie Unii Europejskiej. Lek Spinraza jako jedyny znajduje się w programie lekowym: leczenie rdzeniowego zaniku mięśni.
A zatem powyższe uzasadnienie wskazuje, że zamówienie z przyczyn technicznych o obiektywnym charakterze może być wykonane wyłącznie przez jednego wykonawcę tj. jedynego dystrybutora wskazanego przez jedynego producenta leku. Jednocześnie, jak wynika z programu lekowego, nie istnieje rozsądne rozwiązanie alternatywne lub rozwiązanie zastępcze, a brak konkurencji nie jest wynikiem celowego zawężenia parametrów zamówienia, gdyż w opisie przedmiotu zamówienia wskazana została nazwa substancji czynnej, a nie nazwa handlowa.
Wykonawcom przysługują środki ochrony prawnej przewidziane w Dziale VI ustawy Prawo zamówień publicznych. Szczegółowy opis środków ochrony prawnej znajduje się w Rozdziale XXIV SIWZ.


Winner: Farmacol Logistyka Sp. z o.o.
Award value: 35280000
Public procurement notice: Voluntary Ex Ante Transparency Notice
Published: 2019-07-19
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (‘NSS’)
Country: UK
Contract type: Supplies
Procedure: Negotiated without a prior call for competition
CPV classification: 33600000: Pharmaceutical products
Estimated value: 2465000 GBP

Technical requirements: All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
The medicine awarded to this framework is, and will remain to be, protected by patent for the duration of the Framework Agreement.
The total value in Section II.1.7 and V.2.4 refers to the twenty one (21) months initial duration of the Framework Agreement and the options to extend for up to a total period of twenty seven (27) months.
For detail on the goods awarded to this framework, please contact the named person at the head of this notice.
The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority despatches the VEAT notice and the date on which the Authority proposes to conclude the relevant Framework Agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the Framework Agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the Framework Agreement has been entered into include the setting aside of the decision to award the Framework Agreement to the winning tenderer. The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.


Winner: Aventis Pharma Ltd Trading As Sanofi
Award value: 2465000
Public procurement notice: Modification Of A Contract/Concession During Its Term
Published: 2019-07-19
Buyer: Медицински университет „Проф. д-р Параскев Стоянов“ — гр. Варна
Country: BG
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33100000 | 33122000: Ophthalmological equipment

Technical requirements: Доставка и гаранционно обслужване на апаратура и оборудване за обезпечаване на проекти по фонд „Наука“ на Медицински университет  — Варна по 5 обособени позиции
Оферираният в техническото предложение на изпълнителя апарат за факоемулсификация е с каталожен номер 8065751763 — Centurion Vision System. Каталожният номер е сменен с номер 8065753057 — Centurion Vision System.
На основание чл. 116, ал. 1, т. 7 от Закона за обществените поръчки и чл. 18 от договора във връзка с постъпило писмо от изпълнителя „Бикомед“ ООД с вх. № 023-578/21.6.2019 г. се сключи допълнително споразумение ДД-68/5.7.2019 г. към договор ДДЕ-24/12.6.2019 г. за промяна на каталожния номер на апаратурата, предмет на договора.


Winner: „Бикомед“ ООД
Public procurement notice: Prior Information Notice Without Call For Competition
Published: 2019-07-19
Buyer: One Housing Group
Country: UK
Contract type: Services
CPV classification: 48000000 | 48170000 | 48420000
Award criteria: The most economic tender

Technical requirements: One Housing is looking to procure an asset management platform and invites interested suppliers to participate in a market engagement exercise prior to the commencement of a formal procurement process. The purpose of the engagement exercise is to gauge potential interest in this opportunity and to make sure that we take the most appropriate approach to this procurement.
One Housing is looking to procure a future proof, fully integrated asset management platform providing the following key functionality:
Also, providing the capability to future proof the Asset Management Platform with the following features:
The duration of the contract and potential extension periods shall be detailed in the Contract Notice that will be published following the completion of this market engagement exercise.
To be detailed in the Contract Notice and procurement documents that will be published following the completion of this market engagement exercise.
Prior to the commencement of the formal process, we would like to invite interested suppliers to complete a market engagement questionnaire to gauge potential interest in this opportunity and to make sure that we take the most appropriate approach to this procurement. We are also keen to hear the views of suppliers on what we can do to be attractive clients to work with. This will help to inform our specification and make sure that we are well positioned to achieve value for money and a system that best meets our needs. Once the market engagement has been completed, a formal procurement process will commence however the procedure and precise approach and timescale for the procurement will be dependent upon the feedback from the market.
The market engagement questionnaire can be downloaded and submitted via the EU Supply portal using the links above; the deadline for submission is midday on 30.7.2019.
— no information provided in response to this questionnaire will be later used by One Housing in assessing suppliers during the formal procurement process,
— suppliers who do not respond to this questionnaire will still be able to participate in the procurement process on an equal footing with those who did respond,
— where we think further clarification of a particular response or responses would assist in informing the process we reserve the right to seek further discussion with those potential suppliers, either in writing or in person.

Eligibility requirements: To be detailed in the Contract Notice and procurement documents that will be published following the completion of this market engagement exercise.
Public procurement notice: Prior Information Notice Without Call For Competition
Published: 2019-07-19
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (‘NSS’)
Country: UK
Contract type: Services
CPV classification: 48180000 | 48814000: Medical information systems | 48814400 | 72000000 | 72200000
Estimated value: 1000000 GBP

Technical requirements: Υπηρεσίες τεχνολογίας των πληροφοριών: παροχή συμβουλών, ανάπτυξη λογισμικού, Διαδίκτυο και υποστήριξη
A prison clinical IT system which provides a suitable prescribing functionality linked, in real time, to administration recording along with functionality that facilitates repeat prescribing, stock ordering and reconciliation. In addition the system must facilitate integration with SPS IT systems, such as PR2, or its successor as well as systems supporting health and social care integration. There will also be a requirement to provide implementation, development, training and ongoing system support.
It is the intention of NSS to enter into a contract pursuant to which Prison Clinical IT system(s) is delivered as a managed service. The contract will deliver services to entities constituted pursuant to the National Health Service (Scotland) Act 1978 as amended, Scottish Prison Service. Integration Joint Boards established pursuant to the Public Bodies (Joint Working) (Scotland) Act 2014 and any local authorities established pursuant to the Local Government etc. (Scotland) Act 1994.
This PIN does not constitute a call for competition. Any procurement of any services by NSS will be carried out strictly in accordance with the Public Contracts (Scotland) Regulations 2015.
Participation or non-participation in this pre-procurement market engagement process shall not prevent any supplier from participating in a potential future procurement, nor place any supplier at an advantage or disadvantage in a potential future procurement.
Participation in this pre-procurement market engagement process will be at each supplier’s own cost and expense.
Please complete and return our short market sounding questionnaire by 2:00 p.m. on Wednesday 31.7.2019 by email to george.futcher@nhs.net
Note: To register your interest in this notice and obtain any additional information please visit the Public Contracts Scotland website at https://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=586257


Award value: 1000000
Public procurement notice: Contract Notice
Published: 2019-07-19
Buyer: ADIF
Country: ES
Contract type: Services
Procedure: Open procedure
CPV classification: 71310000 | 71311000: Civil engineering consultancy services | 71311100 | 71311230 | 71356100
Estimated value: 5243942.04 EUR
Submission deadline: 2019-08-28
Award criteria: The most economic tender

Technical requirements: Servicios de consultoría y asistencia técnica para el control y vigilancia de las obras para la integración del ferrocarril en Sant Feliu de Llobregat (Barcelona). Plataforma, vía y línea aerea de contacto
Servicios de consultoría y asistencia técnica para el control y vigilancia de las obras para la integración del ferrocarril en Sant Feliu de Llobregat (Barcelona). Plataforma, vía y línea aerea de contacto.
Adicionalmente, se puede disponer de toda la documentación relativa al procedimiento en la siguiente dirección electrónica: https://contrataciondelestado.es/wps/portal/plataforma&gt


Award value: 5243942.04
Public procurement notice: Contract Notice
Published: 2019-07-19
Buyer: Département de la Vendée
Country: FR
Contract type: Services
Procedure: Open procedure
CPV classification: 71313000: Environmental engineering consultancy services | 90711400 | 92534000
Estimated value: 360000 EUR
Submission deadline: 2019-09-06
Award criteria: The most economic tender

Technical requirements: Услуги по оценка на въздействието върху околната среда (ОВОС) за цели, различни от тези на строителството
Dienstleistungen im Zusammenhang mit der Umweltfolgenabschätzung in anderen Bereichen als dem Bausektor
Υπηρεσίες αξιολόγησης περιβαλλοντικών επιπτώσεων (EIA), εκτός της αξιολόγησης που προορίζεται για κατασκευαστικά έργα
Služby na posudzovanie vplyvu na životné prostredie (EIA) v iných prípadoch ako v súvislosti so stavbou
Inventaires et suivis naturalistes sur les espaces naturels départementaux et autres milieux naturels du Département de la Vendée
Les prestations se dérouleront sur les espaces naturels sensibles, les terrains acquis au titre des mesures compensatoires et autres milieux naturels du Département de la Vendée. Il s'agit, pour chaque lot, d'un accord-cadre mono-attributaire à bons de commande qui sera conclu sans montant minimum et avec un montant maximum annuel défini par lots. L'estimation des achats sur une année d'exécution de l'accord-cadre correspond au détail quantitatif estimatif établi par lots. Le montant des dépenses annuelles est évalué à 90 000 EUR HT en cumul des 4 lots. Date prévisionnelle de début d'exécution des prestations: décembre 2019.
Le marché public pourra être reconduit 3 fois au maximum, par tacite reconduction, pour des périodes de 1 an, ce sans que sa durée totale ne puisse excéder 4 ans.
Une adresse courrier électronique valide afin que le département puisse informer les candidats du rejet de leur offre ou candidature ou du fait que leur offre a été retenue.
— pour les entreprises de création récente, le chiffre d'affaires peut être remplacé par la production de tout document permettant de justifier la capacité financière du candidat (chiffre d'affaires partiel, montant de références en cours, déclaration appropriée de banques notamment),
— déclaration concernant le chiffre d'affaires global et le chiffre d'affaires concernant les fournitures, services ou travaux objet du marché, réalisés au cours des 3 derniers exercices disponibles. Il sera vérifié la capacité économique et financière des candidats à partir des éléments transmis.
— déclaration indiquant l'outillage, le matériel et l'équipement technique dont le candidat dispose pour la réalisation de marchés de même nature,
— déclaration indiquant les effectifs moyens annuels du candidat et l'importance du personnel d'encadrement pour chacune des 3 dernières années,

Eligibility requirements: Une adresse courrier électronique valide afin que le département puisse informer les candidats du rejet de leur offre ou candidature ou du fait que leur offre a été retenue.

Award value: 360000